litlas
ログインアカウント作成

Terry A. Jacobson

1994–2025 年に発表

109
論文数
25,146
被引用数
81
h 指数
107
i10 指数

被引用数

Terry A. Jacobson の年別被引用数1985 年: 被引用 2 件1989 年: 被引用 1 件1992 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 4 件1998 年: 被引用 6 件1999 年: 被引用 2 件2000 年: 被引用 4 件2001 年: 被引用 11 件2002 年: 被引用 9 件2003 年: 被引用 28 件2004 年: 被引用 23 件2005 年: 被引用 36 件2006 年: 被引用 36 件2007 年: 被引用 68 件2008 年: 被引用 65 件2009 年: 被引用 111 件2010 年: 被引用 80 件2011 年: 被引用 130 件2012 年: 被引用 116 件2013 年: 被引用 137 件2014 年: 被引用 135 件2015 年: 被引用 184 件2016 年: 被引用 240 件2017 年: 被引用 211 件2018 年: 被引用 260 件2019 年: 被引用 973 件2020 年: 被引用 1,057 件2021 年: 被引用 915 件2022 年: 被引用 899 件2023 年: 被引用 649 件2024 年: 被引用 999 件2025 年: 被引用 486 件2026 年: 被引用 53 件1986〜1988 年は被引用が無いため表示していません1990〜1991 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,492 件、この内訳の 25.4%中国: 引用元論文 704 件、この内訳の 7.2%イギリス: 引用元論文 632 件、この内訳の 6.5%カナダ: 引用元論文 488 件、この内訳の 5%イタリア: 引用元論文 471 件、この内訳の 4.8%オーストラリア: 引用元論文 394 件、この内訳の 4%ドイツ: 引用元論文 361 件、この内訳の 3.7%オランダ: 引用元論文 277 件、この内訳の 2.8%フランス: 引用元論文 267 件、この内訳の 2.7%スペイン: 引用元論文 241 件、この内訳の 2.5%日本: 引用元論文 206 件、この内訳の 2.1%ポーランド: 引用元論文 189 件、この内訳の 1.9%
0%25.4%その他 31.4%

機関

分野

  • Medicine68.8%
  • Nursing11.7%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Health Professions4.7%
  • Immunology and Microbiology1.4%
  • Agricultural and Biological Sciences1.2%
  • その他4.3%

トピック

  • Lipoproteins and Cardiovascular Health13%
  • Diabetes, Cardiovascular Risks, and Lipoproteins6.8%
  • Fatty Acid Research and Health4.9%
  • Cancer, Lipids, and Metabolism2.9%
  • Atherosclerosis and Cardiovascular Diseases2.2%
  • Medication Adherence and Compliance2.1%
  • その他68.1%

共著者

全論文

検索で開く
  1. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    著者: Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Craig Granowitz, Jean‐Claude Tardif, Christie M. Ballantyne - New England Journal of Medicine 2018 被引用: 3,247

  2. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

    著者: Marlys L. Koschinsky, Archna Bajaj, Michael B. Boffa, Dave L. Dixon, Keith C. Ferdinand, Samuel S. Gidding, Edward A. Gill, Terry A. Jacobson, Erin D. Michos, Maya Safarova, Daniel Soffer, Pam R. Taub, Michael J. Wilkinson, Don P. Wilson, Christie M. Ballantyne - Journal of clinical lipidology 2024 被引用: 269

  3. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    著者: Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Éric Bruckert, Guy De Backer, Ronald M. Krauss, Ulrich Laufs, Raúl D. Santos, Robert A. Hegele, G. Kees Hovingh, Lawrence A. Leiter, François Mach, Winfried März, Connie B. Newman, Olov Wiklund, Terry A. Jacobson, Alberico L. Catapano, M. John Chapman, Henry N. Ginsberg, European Atherosclerosis Society Consensus Panel, Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund - European Heart Journal 2015 被引用: 1,420

  4. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

    著者: Connie B. Newman, David Preiss, Jonathan A. Tobert, Terry A. Jacobson, Robert L. Page, Larry B. Goldstein, Clifford Chin, Lisa R. Tannock, Michael Miller, Geetha Raghuveer, P. Barton Duell, Eliot A. Brinton, Amy W. Pollak, Lynne T. Braun, Francine K. Welty - Arteriosclerosis Thrombosis and Vascular Biology 2019 被引用: 710

  5. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

    著者: Don P. Wilson, Terry A. Jacobson, Peter H. Jones, Marlys L. Koschinsky, Catherine J. McNeal, Børge G. Nordestgaard, Carl E. Orringer - Journal of clinical lipidology 2019 被引用: 504

  6. Safety and efficacy of statin therapy

    著者: Bhavin Adhyaru, Terry A. Jacobson - Nature Reviews Cardiology 2018 被引用: 430

  7. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease

    著者: David S. Siscovick, T. A. Barringer, Amanda M. Fretts, Jason Wu, Alice H. Lichtenstein, Rebecca B. Costello, Penny M. Kris‐Etherton, Terry A. Jacobson, Mary B. Engler, Heather M. Alger, Lawrence J. Appel, Dariush Mozaffarian - Circulation 2017 被引用: 623

  8. The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction

    著者: Carl E. Orringer, Michael J. Blaha, Ron Blankstein, Matthew J. Budoff, Ronald Goldberg, Edward A. Gill, Kevin C. Maki, Laxmi S. Mehta, Terry A. Jacobson - Journal of clinical lipidology 2020 被引用: 219

  9. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

    著者: Ann C. Skulas‐Ray, Peter W.F. Wilson, William S. Harris, Eliot A. Brinton, Penny M. Kris‐Etherton, Chesney K. Richter, Terry A. Jacobson, Mary B. Engler, Michael Miller, Jennifer G. Robinson, Conrad B. Blum, Delfin Rodriguez–Leyva, Sarah D. de Ferranti, Francine K. Welty - Circulation 2019 被引用: 468

  10. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient

    著者: Mary Katherine Cheeley, Joseph J. Saseen, Anandita Agarwala, Sudha Ravilla, Nicole Ciffone, Terry A. Jacobson, Dave L. Dixon, Kevin C. Maki - Journal of clinical lipidology 2022 被引用: 173

  11. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

    著者: François Mach, Kausik K. Ray, Olov Wiklund, Alberto Corsini, Alberico L. Catapano, Éric Bruckert, Guy De Backer, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Ronald M. Krauss, Ulrich Laufs, Lawrence A. Leiter, Winfried März, Børge G. Nordestgaard, Frederick J. Raal, Michael Roden, Raúl D. Santos, Evan A. Stein, Erik S.G. Stroes, Paul D Thompson, Lâle Tokgözoğlu, Georgirene D. Vladutiu, Bariş Gencer, Jane K. Stock, Henry N. Ginsberg, M. John Chapman, European Atherosclerosis Society Consensus Panel - European Heart Journal 2018 被引用: 381

  12. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

    著者: Patrick M. Moriarty, Paul D. Thompson, Christopher P. Cannon, John R. Guyton, Jean Bergeron, Franklin J. Zieve, Éric Bruckert, Terry A. Jacobson, Stephen L. Kopecky, Marie T. Baccara‐Dinet, Yunling Du, Robert Pordy, Daniel A. Gipe - Journal of clinical lipidology 2015 被引用: 467

  13. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy

    著者: Paul M. Ridker, Nader Rifai, Jean MacFadyen, Robert J. Glynn, Lixia Jiao, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Jean‐Claude Tardif, Christie M. Ballantyne, R. Preston Mason, Deepak L. Bhatt - Circulation 2022 被引用: 125

  14. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

    著者: Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson, W. Virgil Brown - Journal of clinical lipidology 2015 被引用: 785

  15. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association

    著者: Bruce A. Warden, John R. Guyton, Adrienne C Kovacs, Jessica A Durham, Laney K. Jones, Dave L. Dixon, Terry A. Jacobson, P. Barton Duell - Journal of clinical lipidology 2022 被引用: 108

  16. The CardioMetabolic Health Alliance

    著者: Laurence Sperling, Jeffrey I. Mechanick, Ian J. Neeland, Cynthia Herrick, Jean‐Pierre Després, Chiadi E. Ndumele, Krishnaswami Vijayaraghavan, Yehuda Handelsman, Gary A. Puckrein, Maria Rosario G. Araneta, Quie K. Blum, Karen Collins, Stephen Cook, Nikhil V. Dhurandhar, Dave L. Dixon, Brent M. Egan, Daphne P. Ferdinand, Lawrence Herman, Scott E. Hessen, Terry A. Jacobson, Russell R. Pate, Robert E. Ratner, Eliot A. Brinton, Alan D. Forker, Laura L. Ritzenthaler, Scott M. Grundy - Journal of the American College of Cardiology 2015 被引用: 284

  17. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study

    著者: Dean G. Karalis, Robert A. Wild, Kevin C. Maki, Ray Gaskins, Terry A. Jacobson, Craig A. Sponseller, Jerome D. Cohen - Journal of clinical lipidology 2016 被引用: 166

  18. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association

    著者: Emily Brown, Amy C. Sturm, Marina Cuchel, Lynne T. Braun, P. Barton Duell, James Underberg, Terry A. Jacobson, Robert A. Hegele - Journal of clinical lipidology 2020 被引用: 156

  19. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association

    著者: Daniel Soffer, Nicholas Marston, Kevin C. Maki, Terry A. Jacobson, Vera Bittner, Jessica M. Peña, George Thanassoulis, Seth S. Martin, Carol F. Kirkpatrick, Salim S. Virani, Dave L. Dixon, Christie M. Ballantyne, Alan T. Remaley - Journal of clinical lipidology 2024 被引用: 77

  20. Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) among Low-Literacy Patients with Chronic Disease

    著者: Sunil Kripalani, Jessica Risser, Margaret E. Gatti, Terry A. Jacobson - Value in Health 2008 被引用: 497

  21. Development and Psychometric Evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in Low-Literacy Patients With Chronic Disease

    著者: Jessica Risser, Terry A. Jacobson, Sunil Kripalani - Journal of Nursing Measurement 2007 被引用: 347

  22. An assessment by the Statin Muscle Safety Task Force: 2014 update

    著者: Robert S. Rosenson, Steven K. Baker, Terry A. Jacobson, Stephen L. Kopecky, Beth A. Parker - Journal of clinical lipidology 2014 被引用: 484

  23. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group

    著者: Peter W.F. Wilson, Terry A. Jacobson, Seth S. Martin, Elizabeth J. Jackson, Ngoc‐Anh Le, Michael H. Davidson, Hubert W. Vesper, Ruth Frikke‐Schmidt, Christie M. Ballantyne, Alan T. Remaley - Journal of clinical lipidology 2021 被引用: 134

  24. Effects of Icosapent Ethyl on Total Ischemic Events

    著者: Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Craig Granowitz, Jean‐Claude Tardif, John Gregson, Stuart Pocock, Christie M. Ballantyne - Journal of the American College of Cardiology 2019 被引用: 256